 | • レポートコード：D0GIR-01834 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、マルチプレックス診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。マルチプレックス診断の種類別市場規模（超高密度マルチプレックスアッセイ（10,000プレックス以上）、高密度マルチプレックスアッセイ（500プレックス-10,000プレックス以下）、中密度マルチプレックスアッセイ（500プレックス以下）、低密度マルチプレックスアッセイ（5プレックス以下）、次世代シーケンスアッセイ）、用途別市場規模（学術研究機関、病院、製薬会社、臨床研究機関、診断研究所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Agilent Technologies、Thermo Fisher Scientific, Inc.、F. Hoffmann-La Roche Ltd.、Bio-Rad Laboratories, Inc.、Hologic, Inc.、BioMerieux SA、Abbott Laboratories、Luminex Corporation、Illumina, Inc.、Siemens Healthineers ・地域別グローバル市場分析 2015年-2020年 ・マルチプレックス診断の北米市場（アメリカ、カナダ、メキシコ） ・マルチプレックス診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・マルチプレックス診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・マルチプレックス診断の南米市場（ブラジル、アルゼンチン） ・マルチプレックス診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：超高密度マルチプレックスアッセイ（10,000プレックス以上）、高密度マルチプレックスアッセイ（500プレックス-10,000プレックス以下）、中密度マルチプレックスアッセイ（500プレックス以下）、低密度マルチプレックスアッセイ（5プレックス以下）、次世代シーケンスアッセイ ・用途別分析：学術研究機関、病院、製薬会社、臨床研究機関、診断研究所 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Multiplexed Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Multiplexed Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Multiplexed Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Multiplexed Diagnostics market has been segmented into:
Very High Density Multiplexed Assays (Above 10,000-plex)
High Density Multiplexed Assays (500 Below plex Below 10,000)
Medium Density Multiplexed Assays (plex Below 500)
Low Density Multiplexed Assays (plex Below 5)
Next Generation Sequencing Assays
By Application, Multiplexed Diagnostics has been segmented into:
Academic Research Institutes
Hospital
Pharmaceutical Companies
Clinical Research Organizations
Diagnostic Laboratories
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Multiplexed Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Multiplexed Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Multiplexed Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the Multiplexed Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Multiplexed Diagnostics Market Share Analysis
Multiplexed Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Multiplexed Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Multiplexed Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in Multiplexed Diagnostics are:
Agilent Technologies
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
Bio-Rad Laboratories, Inc.
Hologic, Inc.
BioMerieux SA
Abbott Laboratories
Luminex Corporation
Illumina, Inc.
Siemens Healthineers
Table of Contents
1 Multiplexed Diagnostics Market Overview
1.1 Product Overview and Scope of Multiplexed Diagnostics
1.2 Classification of Multiplexed Diagnostics by Type
1.2.1 Global Multiplexed Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Multiplexed Diagnostics Revenue Market Share by Type in 2019
1.2.3 Very High Density Multiplexed Assays (Above 10,000-plex)
1.2.4 High Density Multiplexed Assays (500 Below plex Below 10,000)
1.2.5 Medium Density Multiplexed Assays (plex Below 500)
1.2.6 Low Density Multiplexed Assays (plex Below 5)
1.2.7 Next Generation Sequencing Assays
1.3 Global Multiplexed Diagnostics Market by Application
1.3.1 Overview: Global Multiplexed Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Academic Research Institutes
1.3.3 Hospital
1.3.4 Pharmaceutical Companies
1.3.5 Clinical Research Organizations
1.3.6 Diagnostic Laboratories
1.4 Global Multiplexed Diagnostics Market by Regions
1.4.1 Global Multiplexed Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Multiplexed Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Multiplexed Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Multiplexed Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Multiplexed Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Multiplexed Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Multiplexed Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Agilent Technologies
2.1.1 Agilent Technologies Details
2.1.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Agilent Technologies SWOT Analysis
2.1.4 Agilent Technologies Product and Services
2.1.5 Agilent Technologies Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Thermo Fisher Scientific, Inc.
2.2.1 Thermo Fisher Scientific, Inc. Details
2.2.2 Thermo Fisher Scientific, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Thermo Fisher Scientific, Inc. SWOT Analysis
2.2.4 Thermo Fisher Scientific, Inc. Product and Services
2.2.5 Thermo Fisher Scientific, Inc. Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 F. Hoffmann-La Roche Ltd.
2.3.1 F. Hoffmann-La Roche Ltd. Details
2.3.2 F. Hoffmann-La Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.3.4 F. Hoffmann-La Roche Ltd. Product and Services
2.3.5 F. Hoffmann-La Roche Ltd. Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bio-Rad Laboratories, Inc.
2.4.1 Bio-Rad Laboratories, Inc. Details
2.4.2 Bio-Rad Laboratories, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bio-Rad Laboratories, Inc. SWOT Analysis
2.4.4 Bio-Rad Laboratories, Inc. Product and Services
2.4.5 Bio-Rad Laboratories, Inc. Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hologic, Inc.
2.5.1 Hologic, Inc. Details
2.5.2 Hologic, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hologic, Inc. SWOT Analysis
2.5.4 Hologic, Inc. Product and Services
2.5.5 Hologic, Inc. Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 BioMerieux SA
2.6.1 BioMerieux SA Details
2.6.2 BioMerieux SA Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BioMerieux SA SWOT Analysis
2.6.4 BioMerieux SA Product and Services
2.6.5 BioMerieux SA Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Abbott Laboratories
2.7.1 Abbott Laboratories Details
2.7.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Abbott Laboratories SWOT Analysis
2.7.4 Abbott Laboratories Product and Services
2.7.5 Abbott Laboratories Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Luminex Corporation
2.8.1 Luminex Corporation Details
2.8.2 Luminex Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Luminex Corporation SWOT Analysis
2.8.4 Luminex Corporation Product and Services
2.8.5 Luminex Corporation Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Illumina, Inc.
2.9.1 Illumina, Inc. Details
2.9.2 Illumina, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Illumina, Inc. SWOT Analysis
2.9.4 Illumina, Inc. Product and Services
2.9.5 Illumina, Inc. Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Siemens Healthineers
2.10.1 Siemens Healthineers Details
2.10.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Siemens Healthineers SWOT Analysis
2.10.4 Siemens Healthineers Product and Services
2.10.5 Siemens Healthineers Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Multiplexed Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Multiplexed Diagnostics Players Market Share
3.2.2 Top 10 Multiplexed Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Multiplexed Diagnostics Revenue and Market Share by Regions
4.2 North America Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
5 North America Multiplexed Diagnostics Revenue by Countries
5.1 North America Multiplexed Diagnostics Revenue by Countries (2015-2020)
5.2 USA Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe Multiplexed Diagnostics Revenue by Countries
6.1 Europe Multiplexed Diagnostics Revenue by Countries (2015-2020)
6.2 Germany Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Multiplexed Diagnostics Revenue by Countries
7.1 Asia-Pacific Multiplexed Diagnostics Revenue by Countries (2015-2020)
7.2 China Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
8 South America Multiplexed Diagnostics Revenue by Countries
8.1 South America Multiplexed Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Multiplexed Diagnostics by Countries
9.1 Middle East & Africa Multiplexed Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Multiplexed Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global Multiplexed Diagnostics Market Forecast by Type (2019-2024)
10.3 Very High Density Multiplexed Assays (Above 10,000-plex) Revenue Growth Rate (2015-2025)
10.4 High Density Multiplexed Assays (500 Below plex Below 10,000) Revenue Growth Rate (2015-2025)
10.5 Medium Density Multiplexed Assays (plex Below 500) Revenue Growth Rate (2015-2025)
10.6 Low Density Multiplexed Assays (plex Below 5) Revenue Growth Rate (2015-2025)
10.7 Next Generation Sequencing Assays Revenue Growth Rate (2015-2025)
11 Global Multiplexed Diagnostics Market Segment by Application
11.1 Global Multiplexed Diagnostics Revenue Market Share by Application (2015-2020)
11.2 Multiplexed Diagnostics Market Forecast by Application (2019-2024)
11.3 Academic Research Institutes Revenue Growth (2015-2020)
11.4 Hospital Revenue Growth (2015-2020)
11.5 Pharmaceutical Companies Revenue Growth (2015-2020)
11.6 Clinical Research Organizations Revenue Growth (2015-2020)
11.7 Diagnostic Laboratories Revenue Growth (2015-2020)
12 Global Multiplexed Diagnostics Market Size Forecast (2021-2025)
12.1 Global Multiplexed Diagnostics Market Size Forecast (2021-2025)
12.2 Global Multiplexed Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America Multiplexed Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe Multiplexed Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Multiplexed Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America Multiplexed Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Multiplexed Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Multiplexed Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Multiplexed Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Multiplexed Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Multiplexed Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Agilent Technologies Corporate Information, Location and Competitors
Table 6. Agilent Technologies Multiplexed Diagnostics Major Business
Table 7. Agilent Technologies Multiplexed Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. Agilent Technologies SWOT Analysis
Table 9. Agilent Technologies Multiplexed Diagnostics Product and Solutions
Table 10. Agilent Technologies Multiplexed Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Thermo Fisher Scientific, Inc. Corporate Information, Location and Competitors
Table 12. Thermo Fisher Scientific, Inc. Multiplexed Diagnostics Major Business
Table 13. Thermo Fisher Scientific, Inc. Multiplexed Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. Thermo Fisher Scientific, Inc. SWOT Analysis
Table 15. Thermo Fisher Scientific, Inc. Multiplexed Diagnostics Product and Solutions
Table 16. Thermo Fisher Scientific, Inc. Multiplexed Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. F. Hoffmann-La Roche Ltd. Corporate Information, Location and Competitors
Table 18. F. Hoffmann-La Roche Ltd. Multiplexed Diagnostics Major Business
Table 19. F. Hoffmann-La Roche Ltd. Multiplexed Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 21. F. Hoffmann-La Roche Ltd. Multiplexed Diagnostics Product and Solutions
Table 22. F. Hoffmann-La Roche Ltd. Multiplexed Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bio-Rad Laboratories, Inc. Corporate Information, Location and Competitors
Table 24. Bio-Rad Laboratories, Inc. Multiplexed Diagnostics Major Business
Table 25. Bio-Rad Laboratories, Inc. Multiplexed Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. Bio-Rad Laboratories, Inc. SWOT Analysis
Table 27. Bio-Rad Laboratories, Inc. Multiplexed Diagnostics Product and Solutions
Table 28. Bio-Rad Laboratories, Inc. Multiplexed Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Hologic, Inc. Corporate Information, Location and Competitors
Table 30. Hologic, Inc. Multiplexed Diagnostics Major Business
Table 31. Hologic, Inc. Multiplexed Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. Hologic, Inc. SWOT Analysis
Table 33. Hologic, Inc. Multiplexed Diagnostics Product and Solutions
Table 34. Hologic, Inc. Multiplexed Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. BioMerieux SA Corporate Information, Location and Competitors
Table 36. BioMerieux SA Multiplexed Diagnostics Major Business
Table 37. BioMerieux SA Multiplexed Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. BioMerieux SA SWOT Analysis
Table 39. BioMerieux SA Multiplexed Diagnostics Product and Solutions
Table 40. BioMerieux SA Multiplexed Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Abbott Laboratories Corporate Information, Location and Competitors
Table 42. Abbott Laboratories Multiplexed Diagnostics Major Business
Table 43. Abbott Laboratories Multiplexed Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. Abbott Laboratories SWOT Analysis
Table 45. Abbott Laboratories Multiplexed Diagnostics Product and Solutions
Table 46. Abbott Laboratories Multiplexed Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Luminex Corporation Corporate Information, Location and Competitors
Table 48. Luminex Corporation Multiplexed Diagnostics Major Business
Table 49. Luminex Corporation Multiplexed Diagnostics Total Revenue (USD Million) (2017-2018)
Table 50. Luminex Corporation SWOT Analysis
Table 51. Luminex Corporation Multiplexed Diagnostics Product and Solutions
Table 52. Luminex Corporation Multiplexed Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Illumina, Inc. Corporate Information, Location and Competitors
Table 54. Illumina, Inc. Multiplexed Diagnostics Major Business
Table 55. Illumina, Inc. Multiplexed Diagnostics Total Revenue (USD Million) (2017-2018)
Table 56. Illumina, Inc. SWOT Analysis
Table 57. Illumina, Inc. Multiplexed Diagnostics Product and Solutions
Table 58. Illumina, Inc. Multiplexed Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Siemens Healthineers Corporate Information, Location and Competitors
Table 60. Siemens Healthineers Multiplexed Diagnostics Major Business
Table 61. Siemens Healthineers Multiplexed Diagnostics Total Revenue (USD Million) (2017-2018)
Table 62. Siemens Healthineers SWOT Analysis
Table 63. Siemens Healthineers Multiplexed Diagnostics Product and Solutions
Table 64. Siemens Healthineers Multiplexed Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Multiplexed Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 66. Global Multiplexed Diagnostics Revenue Share by Players (2015-2020)
Table 67. Global Multiplexed Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Multiplexed Diagnostics Revenue Market Share by Regions (2015-2020)
Table 69. North America Multiplexed Diagnostics Revenue by Countries (2015-2020)
Table 70. North America Multiplexed Diagnostics Revenue Market Share by Countries (2015-2020)
Table 71. Europe Multiplexed Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Multiplexed Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Multiplexed Diagnostics Revenue by Countries (2015-2020)
Table 74. South America Multiplexed Diagnostics Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Multiplexed Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Multiplexed Diagnostics Revenue Market Share by Countries (2015-2020)
Table 77. Global Multiplexed Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 78. Global Multiplexed Diagnostics Revenue Share by Type (2015-2020)
Table 79. Global Multiplexed Diagnostics Revenue Forecast by Type (2021-2025)
Table 80. Global Multiplexed Diagnostics Revenue by Application (2015-2020)
Table 81. Global Multiplexed Diagnostics Revenue Share by Application (2015-2020)
Table 82. Global Multiplexed Diagnostics Revenue Forecast by Application (2021-2025)
Table 83. Global Multiplexed Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Multiplexed Diagnostics Picture
Figure 2. Global Multiplexed Diagnostics Revenue Market Share by Type in 2019
Figure 3. Very High Density Multiplexed Assays (Above 10,000-plex) Picture
Figure 4. High Density Multiplexed Assays (500 Below plex Below 10,000) Picture
Figure 5. Medium Density Multiplexed Assays (plex Below 500) Picture
Figure 6. Low Density Multiplexed Assays (plex Below 5) Picture
Figure 7. Next Generation Sequencing Assays Picture
Figure 8. Multiplexed Diagnostics Revenue Market Share by Application in 2019
Figure 9. Academic Research Institutes Picture
Figure 10. Hospital Picture
Figure 11. Pharmaceutical Companies Picture
Figure 12. Clinical Research Organizations Picture
Figure 13. Diagnostic Laboratories Picture
Figure 14. Global Multiplexed Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Multiplexed Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Multiplexed Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Multiplexed Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Multiplexed Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Multiplexed Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Multiplexed Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Multiplexed Diagnostics Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Multiplexed Diagnostics Revenue Market Share in 2019
Figure 23. Global Top 10 Players Multiplexed Diagnostics Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Multiplexed Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Multiplexed Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 27. Global Multiplexed Diagnostics Revenue Market Share by Regions in 2018
Figure 28. North America Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. Europe Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 31. South America Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 33. North America Multiplexed Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 34. North America Multiplexed Diagnostics Revenue Market Share by Countries in 2019
Figure 35. USA Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 36. Canada Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 38. Europe Multiplexed Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Multiplexed Diagnostics Revenue Market Share by Countries in 2019
Figure 40. Germany Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. UK Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. France Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 43. Russia Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 44. Italy Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Multiplexed Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Multiplexed Diagnostics Revenue Market Share by Countries in 2019
Figure 47. China Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. Japan Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. Korea Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 50. India Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 52. South America Multiplexed Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 53. South America Multiplexed Diagnostics Revenue Market Share by Countries in 2019
Figure 54. Brazil Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Multiplexed Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Multiplexed Diagnostics Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 59. UAE Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Multiplexed Diagnostics Revenue and Growth Rate (2015-2020)
Figure 62. Global Multiplexed Diagnostics Revenue Share by Type (2015-2020)
Figure 63. Global Multiplexed Diagnostics Revenue Share by Type in 2019
Figure 64. Global Multiplexed Diagnostics Market Share Forecast by Type (2021-2025)
Figure 65. Global Very High Density Multiplexed Assays (Above 10,000-plex) Revenue Growth Rate (2015-2020)
Figure 66. Global High Density Multiplexed Assays (500 Below plex Below 10,000) Revenue Growth Rate (2015-2020)
Figure 67. Global Medium Density Multiplexed Assays (plex Below 500) Revenue Growth Rate (2015-2020)
Figure 68. Global Low Density Multiplexed Assays (plex Below 5) Revenue Growth Rate (2015-2020)
Figure 69. Global Next Generation Sequencing Assays Revenue Growth Rate (2015-2020)
Figure 70. Global Multiplexed Diagnostics Revenue Share by Application (2015-2020)
Figure 71. Global Multiplexed Diagnostics Revenue Share by Application in 2019
Figure 72. Global Multiplexed Diagnostics Market Share Forecast by Application (2021-2025)
Figure 73. Global Academic Research Institutes Revenue Growth Rate (2015-2020)
Figure 74. Global Hospital Revenue Growth Rate (2015-2020)
Figure 75. Global Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 76. Global Clinical Research Organizations Revenue Growth Rate (2015-2020)
Figure 77. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 78. Global Multiplexed Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Multiplexed Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Multiplexed Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Multiplexed Diagnostics Revenue Market Forecast (2021-2025)
Figure 82. Europe Multiplexed Diagnostics Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Multiplexed Diagnostics Revenue Market Forecast (2021-2025)
Figure 84. South America Multiplexed Diagnostics Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Multiplexed Diagnostics Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
迅速医療診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Rapid Medical Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…- 一般インフルエンザ診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The General Influenza Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 高密度ポリエチレンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global High Density Polyethylene market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.5% in the forecast period of 2020 to 2025 and will expected to reach USD 66540 million by 2025, from USD 60290 million in 2019. The High Density…
- 高密度コネクタの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global High Density Connectors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The High Density Connecto…
- ポイントオブケア（POC）診断用ポリメラーゼ連鎖反応（PCR）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx mi…